Compound
Everything we've written on Growth hormone secretagogues — 12 articles covering the mechanism, the evidence, comparisons, and practical considerations.
12 articles
Origins and discoveryThe bodybuilding peptide underground — a history nobody wroteThe forum post was dated 2003. The user went by a handle that combined a number and an animal. He'd been running a protocol of GHRP-6 and CJC-1295 for twelve weeks, dosing before bed, and he was reporting on sleep quality, appetite, and recovery between sessions. He'd gotten the peptides from a research chemical company in eastern Europe. He wasn't sure about the purity. He had no bloodwork. He was dosing based on a protocol he'd assembled from three other forum threads, one of which cited a paper he hadn't read. He said it was working. He said he thought he understood why.11 min readPeptide scienceThe GH secretagogue family tree — Sermorelin, CJC-1295, Ipamorelin, GHRPs, MK-677, HexarelinSomeone hands you a menu of GH secretagogues and the list looks, at first pass, like a collection of arbitrary letter-and-number combinations. Sermorelin. CJC-1295. GHRP-2. Ipamorelin. Hexarelin. MK-677. The names don't tell you what they do or how they differ, and the conversations online treat them as loosely interchangeable — stack this with that, dose it like this — without explaining the structural logic underneath. That structural logic matters. These are not the same compound with different labels. They work through different receptors, produce different hormonal profiles, carry different side-effect considerations, and have meaningfully different durations of action. Understanding the family tree is what separates informed use from guesswork.9 min readGrowth hormone and recoveryGHRP-2 in plain English — the GH releaser with appetite and cortisol bonusYou're three weeks into a recovery protocol and you notice something unexpected: you're hungry in a way you weren't before. Not the ordinary hunger that builds over hours since your last meal. Something more insistent, arriving earlier, harder to dismiss. Your sleep feels deeper. Your morning mood is better. But the hunger is real, and it wasn't on your list of expected effects.8 min readGrowth hormone and recoveryGHRP-6 in plain English — the appetite-stimulating GH releaserYou take the injection and forty-five minutes later you're standing in front of an open refrigerator, not because you're hungry in the ordinary sense but because something in your body has decided, with unusual conviction, that food is necessary right now. You weren't thinking about eating before you injected. You're thinking about nothing but eating now. The sensation is specific enough to be disorienting — not the soft background hum of an appetite building over hours, but something that arrives like a signal.8 min readGrowth hormone and recoveryThe Ipamorelin + CJC-1295 stack — why everyone runs itThere's a moment in most people's introduction to GH peptides when they discover that nobody seems to use ipamorelin alone. Every forum, every compounding clinic protocol, every practitioner guide points to the same pairing: ipamorelin with CJC-1295. The combination has become so standard that the two compounds are often discussed as though they're a single thing. But the reason this combination became dominant is not arbitrary, and understanding the mechanism behind it explains why the pairing is more than a convention — it's mechanistic logic that follows from how growth hormone release actually works.3 min readGrowth hormone and recoveryWhat people are reporting about IpamorelinThis article summarizes experiences reported in public online communities including Reddit, longevity forums, and discussion boards. We are not advocating human use of any compound discussed here. Many of the peptides discussed are not FDA-approved for the uses described, and some are explicitly not approved for human or veterinary use. What follows is a synthesis of what people have reported, presented to give readers context on the public conversation — not as guidance, not as evidence of safety or efficacy, and not as a recommendation. Decisions about any compound should be made with a qualified prescribing provider after a full medical evaluation.5 min readGrowth hormone and recoveryIpamorelin in plain English — the cleanest of the secretagoguesIn the late 1990s, a team of researchers at Novo Nordisk was working through a screening problem. They had growth hormone-releasing peptides — GHRPs — that worked. GHRP-2, GHRP-6, Hexarelin: all of them stimulated pituitary GH release reliably, and some of them did it dramatically. The problem was that "worked" turned out to cover too much territory. The same compounds that elevated GH also elevated cortisol. They elevated prolactin. GHRP-6 in particular produced significant appetite stimulation — not a mild increase but a noticeable, sometimes uncomfortable hunger response. The researchers had tools that did the thing they were designed to do, but they did it while simultaneously pulling levers that nobody had asked them to pull.4 min readCompounding and compliancePeptide stacks for longevity vs performance — different goals, different combinationsYou're 48. You train four days a week, you sleep reasonably well, your labs are broadly fine, and you've been reading about peptides for six months. You have a list of compounds and no coherent framework for how they fit together. Someone told you BPC-157 was good. Someone else said Epitalon was what you actually needed. A forum thread convinced you that Ipamorelin plus CJC-1295 was the move, but then another thread contradicted it with an argument about IGF-1 and cancer risk that you haven't been able to shake. The problem isn't information. You have too much information. The problem is a framework for understanding what you're actually trying to do.10 min readCompounding and complianceThe philosophy of peptide stacking — when one + one equals more than two, and when it equals lessYou've been reading the peptide literature long enough to notice a pattern. The protocols get larger over time. What started as a single compound becomes a stack. The stack acquires additions. You're now looking at someone's ten-compound regimen listed on a forum, followed by testimonials about transformative results, and you're trying to figure out whether the logic holds — whether more is actually more — or whether something else is happening.10 min readCompounding and complianceStacking peptides without redundancy — the overlap nobody talks aboutThe logic feels obvious at first. You find one peptide that seems to be doing something useful, and then you find another one, and then you think: why wouldn't I take both? More inputs, more outputs. It's the same reasoning that leads people to take five supplements when one would have done the work — not because they're irrational, but because when something is working, the instinct is to add more things that might also work.8 min readAnti-aging and cellular healthPeptides in frailty — what the geriatric medicine evidence suggestsYou're watching your father lose weight he wasn't trying to lose. He gets tired walking to the mailbox, something that wasn't true eighteen months ago. He moves more carefully now, and the carefulness has a different quality than before — less deliberate, more uncertain. His grip strength is down. He's had one fall. His doctor says he's in the frailty range and talks about nutrition and maybe physical therapy. You've been reading about peptides and wondering if any of it applies to him.9 min readGrowth hormone and recoveryWhat people are reporting about Sermorelin over monthsThis article summarizes experiences reported in public online communities including Reddit, longevity forums, and discussion boards. We are not advocating human use of any compound discussed here. Many of the peptides discussed are not FDA-approved for the uses described, and some are explicitly not approved for human or veterinary use. What follows is a synthesis of what people have reported, presented to give readers context on the public conversation — not as guidance, not as evidence of safety or efficacy, and not as a recommendation. Decisions about any compound should be made with a qualified prescribing provider after a full medical evaluation.8 min read